TNF and chronic obstructive pulmonary disease: Network meta-analysis showed that the SUCRA of reducing the TNF-α in COPD patients in Atorvastatin and Simvastatin were 51.0 and 89.2%, respectively (Additional file 12: Table S2 and Additional file 13: Figure S11).